ApaTech to solidy growth with Actifuse
This article was originally published in Clinica
Executive Summary
No one can accuse Simon Cartmell of resting on his laurels. After joining ApaTech in 2003, the CEO led the orthobiologics company in the crossover between R&D and commercialisation, and helped it more than double its revenue each year, for the last three years.